From emerging therapies to earlier intervention and psychosocial support, Dermatology Times looks back at key alopecia areata developments in 2026.
News|Articles|August 28, 2026
The Practice Brief: What Mattered in September
Author(s)Shannon Heaning, Content Associate
Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.
Advertisement
Advertisement
Help your practice thrive—one week at a time.
Related to this article
This review of the latest dermatological studies includes insights on artificial intelligence, interstitial granulomatous dermatitis and atopic dermatitis
Maui Derm NP+PA Fall 2026 brought APPs together for updates spanning inflammatory disease, oncology, emerging therapies, and diagnostic challenges.
Faculty from the Cutaneous Oncology Workshop answer practical questions spanning skin cancer prevention, diagnosis, treatment, and follow-up.
Two new Neutrogena facial sunscreens incorporate bemotrizinol, the first new sunscreen active ingredient added to the US OTC monograph in decades.
This review of the latest dermatological studies includes insights on stem cell therapies for skin rejuvenation, smoke exposure in HS, hair loss in pediatric IBD, and more.
An HS toolbox with wound care, symptom relief, and personal care supplies can help patients stay prepared for unexpected flares.
The inaugural workshop explored skin cancer care from prevention and diagnosis through systemic therapy, radiation, and multidisciplinary management.
Advertisement
Advertisement